XML 15 R5.htm IDEA: XBRL DOCUMENT v3.23.2
Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Common Stock
Employees
Common Stock
Executive Officer [Member]
Common Stock
Consultants
Common Stock
Director
Common Stock
Paid-In Capital [Member]
Employees
Paid-In Capital [Member]
Executive Officer [Member]
Paid-In Capital [Member]
Consultants
Paid-In Capital [Member]
Retained Earnings (Accumulated Deficit) [Member]
Noncontrolling Interest [Member]
Employees
Executive Officer [Member]
Consultants
Total
Balances at Dec. 31, 2021         $ 20       $ 103,039 $ (28,779) $ 662       $ 74,942
Balances (in shares) at Dec. 31, 2021         19,571,119                    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                              
Compensation expense related to stock options and restricted stock                 30           30
Net income (loss)                   (3,487) (252)       (3,739)
Balances at Mar. 31, 2022         $ 20       103,069 (32,266) 410       71,233
Balances (in shares) at Mar. 31, 2022         19,571,119                    
Balances at Dec. 31, 2021         $ 20       103,039 (28,779) 662       74,942
Balances (in shares) at Dec. 31, 2021         19,571,119                    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                              
Net income (loss)                             5,450
Balances at Jun. 30, 2022         $ 20       103,490 (22,776) 109       80,843
Balances (in shares) at Jun. 30, 2022         19,624,860                    
Balances at Mar. 31, 2022         $ 20       103,069 (32,266) 410       71,233
Balances (in shares) at Mar. 31, 2022         19,571,119                    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                              
Compensation expense related to stock options and restricted stock                 402           402
Shares issued related to/in connection with stock grant           $ 50 $ 281 $ 33       $ 50 $ 281 $ 33  
Shares issued related to/in connection with stock grant 33,557 178,727 20,064 50,000                      
Shares issued to consultant in connection with Isaac Mizrahi sale transaction                 97           97
Shares issued to consultant in connection with Isaac Mizrahi sale transaction         65,275                    
Shares repurchased in exchange for withholding taxes           $ (357) $ (85)         $ (357) $ (85)    
Shares repurchased in exchange for withholding taxes (in shares) (240,000) (53,882)                          
Net income (loss)                   9,490 (301)       9,189
Balances at Jun. 30, 2022         $ 20       103,490 (22,776) 109       80,843
Balances (in shares) at Jun. 30, 2022         19,624,860                    
Balances at Dec. 31, 2022         $ 20       103,592 (32,797) (676)       70,139
Balances (in shares) at Dec. 31, 2022         19,624,860                    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                              
Compensation expense related to stock options and restricted stock                 51           51
Shares issued to consultant in connection with stock grant                 6           6
Shares issued to consultant in connection with stock grant (in shares)         8,334                    
Net income (loss)                   (5,643) (295)       (5,938)
Balances at Mar. 31, 2023         $ 20       103,649 (38,440) (971)       64,258
Balances (in shares) at Mar. 31, 2023         19,633,194                    
Balances at Dec. 31, 2022         $ 20       103,592 (32,797) (676)       70,139
Balances (in shares) at Dec. 31, 2022         19,624,860                    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                              
Net income (loss)                             (9,639)
Balances at Jun. 30, 2023         $ 20       103,715 (41,908) (1,204)       60,623
Balances (in shares) at Jun. 30, 2023         19,700,656                    
Balances at Mar. 31, 2023         $ 20       103,649 (38,440) (971)       64,258
Balances (in shares) at Mar. 31, 2023         19,633,194                    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                              
Compensation expense related to stock options and restricted stock                 27           27
Shares issued to consultant in connection with stock grant                 39           39
Shares issued to consultant in connection with stock grant (in shares)         58,334                    
Shares issued on exercise of stock options, net (in shares)         9,128                    
Net income (loss)                   (3,468) (233)       (3,701)
Balances at Jun. 30, 2023         $ 20       $ 103,715 $ (41,908) $ (1,204)       $ 60,623
Balances (in shares) at Jun. 30, 2023         19,700,656